Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Chubb
UBS
Fuji
Covington
Colorcon
Medtronic
McKesson
QuintilesIMS

Generated: January 17, 2018

DrugPatentWatch Database Preview

MEPROBAMATE Drug Profile

« Back to Dashboard

When do Meprobamate patents expire, and what generic alternatives are available?

Meprobamate is a drug marketed by Alembic Pharms Ltd, Aurolife Pharma Llc, Barr, Elkins Sinn, Heather, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Ivc Inds, Lannett, Lederle, Lee Km, Mallard, Mk Labs, Mylan, Nexgen Pharma Inc, Parke Davis, Perrigo, Pharmavite, Purepac Pharm, Pvt Form, Roxane, Sandoz, Scherer Labs, Solvay, Stanlabs Pharm, Sun Pharm Industries, Tablicaps, Taro, Usl Pharma, Valeant Pharm Intl, Vangard, Watson Labs, West Ward, Whiteworth Town Plsn, and Par Pharm. and is included in forty-seven NDAs.

The generic ingredient in MEPROBAMATE is aspirin; meprobamate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.

US Patents and Regulatory Information for MEPROBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stanlabs Pharm MEPROBAMATE meprobamate TABLET;ORAL 014474-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm MEPROBAMATE meprobamate TABLET;ORAL 084804-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharm Intl MEPROBAMATE meprobamate TABLET;ORAL 015139-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Whiteworth Town Plsn MEPROBAMATE meprobamate TABLET;ORAL 083830-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro MEPROBAMATE meprobamate TABLET;ORAL 200998-001 May 23, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharm Intl MEPROBAMATE meprobamate TABLET;ORAL 015139-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MEPROBAMATE meprobamate TABLET;ORAL 085721-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Whiteworth Town Plsn MEPROBAMATE meprobamate TABLET;ORAL 083442-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis MEPROBAMATE meprobamate TABLET;ORAL 084744-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm MEPROBAMATE meprobamate TABLET;ORAL 084804-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
UBS
Healthtrust
Chinese Patent Office
McKinsey
Covington
Dow
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot